CORDIS · 101137196 · HORIZON
POINT Preventing non-communicable diseases caused by the post-acute phase of cOvid-19 INfecTion
Coordinator: KOBENHAVNS UNIVERSITET (DK)
The post-acute phase (PAP) of COVID-19, occurring ≥4 months after the acute phase, is associated with an increased risk for the development of non-communicable diseases (NCDs). The risk of complications in this phase does not depend on the severity of the acute phase. In the EU, more than 183 million cases of COVID-19 have been reported and up to 70% of patients suffer reduced organ function in the PAP. Our conservative estimate it that 5% of people who have suffered COVID-19 are at risk of developing NCDs of the pulmonary, cardiovascular and renal systems due to the PAP.To avoid the signific…
About Horizon Europe (2021–2027)
Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.
EU contribution: €6.7M awarded to the consortium. The project runs over approximately 4 years from 2024-01-01 to 2027-12-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from DK
see all →- GreenHyScale — 100 MW Green hydrogen production in a replicable and scalable industrial hosting environment101036935 · H2020 · €30.0M
- COMPARE — COllaborative Management Platform for detection and Analyses of (Re-)emerging and foodborne outbreaks in Europe643476 · H2020 · €20.8M
- ARCHIMEDES — Achieving Real Change with Innovative Transport Measures Demonstrating Energy Savings218940 · FP7 · €16.0M
- Green2Ice — When was Greenland ‘green’? – Perspectives from basal ice and sediments from ice cores.101072180 · HORIZON · €13.9M
- METRIQS — Metamaterial Interfaces for Quantum Electronics101167432 · HORIZON · €13.3M
- SUBNORDICA — Beyond submerged landscapes - defining human response to postglacial sea-level rise and climate change101119164 · HORIZON · €13.2M
Other HORIZON projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon Europe through a joint programme of the members of the EUROfusion consortium101052200 · DE · €549.4M
- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · ES · €206.9M
- PARC — Partnership for the Assessment of Risks from Chemicals101057014 · FR · €200.0M
- EIT RM BP23-25 — EIT RawMatrials Business Plan 2023-2025101113034 · DE · €155.5M
- SGA1-HE — COST: Europe's most empowering research programme Strengthening science and innovation through research networking101052416 · BE · €153.0M
- EIT HEI — EIT Higher Education Initiative - Scaling Europe’s Innovation Ecosystems101270329 · DE · €130.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-RIA funding scheme.
- What is the EU contribution?
- The European Commission contributes €6.7M toward a total project budget of €6.7M.
- Which EU programme funds it?
- The project is funded under Horizon Europe (2021–2027), call HORIZON-HLTH-2023-DISEASE-03.
- Who coordinates the project?
- The project is coordinated by KOBENHAVNS UNIVERSITET (DK).
- What is the project timeline?
- The project runs from 2024-01-01 to 2027-12-31 — approximately 4 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101137196.